Tender detail

Galsulfase for enzyme replacement therapy

Summary

The tender concerns galsulfase for enzyme replacement therapy. This is a supply contract for medicinal products, and the bidder must hold a wholesale licence for human medicines. The bidder must also take account of sanctions-related requirements, joint tender and trade secret confirmations, and the bid must comply with the tender documents.

Reference number
308483-0000
Buyer
Sihtasutus Viljandi Haigla
Country
Estonia (EST)
Procedure
Open procedure
CPV
33610000 Medicinal products for the alimentary tract and metabolism
Deadline
2026-04-17
Status
Evaluation
Contract subject
Supplies
Estimated value
215 999,99 EUR
Source
RHR

Participation requirements

Tender requirements are available in the official tender documents.

Compliance requirements

The tender documents include mandatory exclusion grounds based on final convictions, at least for participation in a criminal organisation, corruption and fraud. If such a ground applies, the bidder may be allowed to show self-cleaning measures, but this depends on the tender documents and the applicable rules. The machine-readable notice did not include the full list of exclusion grounds, so the official tender documents must be checked.

Qualification criteria and exclusion grounds

The bidder must hold a wholesale licence for human medicines. The contracting authority will check this in the medicines licence register. When submitting the bid, the bidder must confirm that the bid complies with the tender documents, that any equivalence has been explained and supporting evidence has been attached where needed, and that the bid price is submitted in the required structure. If this is a joint tender, a power of attorney for the joint bidders must be attached. The bid submission form must be completed. The machine-readable notice did not include any more precise qualification or compliance requirements; these must be checked in the tender documents.